Specifically, it has also been shown that, in patients with atherosclerosis, high systemic levels of ET-1 are associated with significant carotid epithelial dysfunctions, underlining the fundamental inhibitory role of NO exercised by ET-134. This evidence concerns the gene EDN1 and atherosclerosis.